Annual EBITDA
-$99.00 M
+$319.97 M+76.37%
December 31, 2023
Summary
- As of February 7, 2025, CDLX annual EBITDA is -$99.00 million, with the most recent change of +$319.97 million (+76.37%) on December 31, 2023.
- During the last 3 years, CDLX annual EBITDA has fallen by -$58.22 million (-142.76%).
- CDLX annual EBITDA is now -1095.56% below its all-time high of -$8.28 million, reached on December 31, 2017.
Performance
CDLX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$135.30 M
-$140.53 M-2688.01%
September 30, 2024
Summary
- As of February 7, 2025, CDLX quarterly EBITDA is -$135.30 million, with the most recent change of -$140.53 million (-2688.01%) on September 30, 2024.
- Over the past year, CDLX quarterly EBITDA has dropped by -$140.53 million (-2688.01%).
- CDLX quarterly EBITDA is now -618.04% below its all-time high of $26.12 million, reached on March 31, 2022.
Performance
CDLX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$238.00 M
-$119.66 M-101.11%
September 30, 2024
Summary
- As of February 7, 2025, CDLX TTM EBITDA is -$238.00 million, with the most recent change of -$119.66 million (-101.11%) on September 30, 2024.
- Over the past year, CDLX TTM EBITDA has dropped by -$119.66 million (-101.11%).
- CDLX TTM EBITDA is now -9043.41% below its all-time high of -$2.60 million, reached on December 31, 2016.
Performance
CDLX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDLX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.4% | -2688.0% | -101.1% |
| 3 y3 years | -142.8% | -2559.7% | -169.8% |
| 5 y5 years | -112.9% | -2559.7% | -169.8% |
CDLX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.2% | +76.4% | -618.0% | +63.2% | -435.2% | +46.1% |
| 5 y | 5-year | -720.9% | +76.4% | -618.0% | +63.2% | -1873.3% | +46.1% |
| alltime | all time | -1095.6% | +76.4% | -618.0% | +63.2% | -9043.4% | +46.1% |
Cardlytics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$135.30 M(-2688.0%) | -$238.00 M(+101.1%) |
| Jun 2024 | - | $5.23 M(-133.2%) | -$118.34 M(-13.8%) |
| Mar 2024 | - | -$15.74 M(-82.9%) | -$137.29 M(+38.7%) |
| Dec 2023 | -$99.00 M(-76.4%) | -$92.19 M(+489.3%) | -$99.00 M(-73.6%) |
| Sep 2023 | - | -$15.64 M(+14.0%) | -$374.69 M(+10.2%) |
| Jun 2023 | - | -$13.72 M(-160.9%) | -$340.03 M(-22.9%) |
| Mar 2023 | - | $22.54 M(-106.1%) | -$441.27 M(+0.8%) |
| Dec 2022 | -$418.98 M(+375.0%) | -$367.88 M(-2033.8%) | -$437.69 M(+484.3%) |
| Sep 2022 | - | $19.02 M(-116.5%) | -$74.91 M(-40.3%) |
| Jun 2022 | - | -$114.96 M(-540.2%) | -$125.42 M(+182.0%) |
| Mar 2022 | - | $26.12 M(-613.4%) | -$44.47 M(-49.6%) |
| Dec 2021 | -$88.21 M(+116.3%) | -$5.09 M(-83.8%) | -$88.21 M(+4.9%) |
| Sep 2021 | - | -$31.49 M(-7.4%) | -$84.10 M(+29.8%) |
| Jun 2021 | - | -$34.01 M(+93.0%) | -$64.81 M(+34.6%) |
| Mar 2021 | - | -$17.62 M(+1705.5%) | -$48.14 M(+18.0%) |
| Dec 2020 | -$40.78 M | -$976.00 K(-92.0%) | -$40.78 M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$12.20 M(-29.6%) | -$35.81 M(+20.1%) |
| Jun 2020 | - | -$17.34 M(+68.9%) | -$29.81 M(+70.7%) |
| Mar 2020 | - | -$10.26 M(-357.1%) | -$17.46 M(+44.8%) |
| Dec 2019 | -$12.06 M(-74.1%) | $3.99 M(-164.4%) | -$12.06 M(-55.4%) |
| Sep 2019 | - | -$6.20 M(+24.3%) | -$27.07 M(-3.4%) |
| Jun 2019 | - | -$4.99 M(+2.5%) | -$28.01 M(-17.9%) |
| Mar 2019 | - | -$4.86 M(-55.8%) | -$34.10 M(-26.7%) |
| Dec 2018 | -$46.50 M(+461.5%) | -$11.01 M(+54.0%) | -$46.50 M(+25.8%) |
| Sep 2018 | - | -$7.15 M(-35.5%) | -$36.97 M(+24.4%) |
| Jun 2018 | - | -$11.08 M(-35.8%) | -$29.72 M(+28.1%) |
| Mar 2018 | - | -$17.26 M(+1059.7%) | -$23.19 M(+89.8%) |
| Dec 2017 | -$8.28 M(-68.3%) | -$1.49 M(-1588.0%) | -$12.22 M(-8.4%) |
| Sep 2017 | - | $100.00 K(-102.2%) | -$13.34 M(-0.7%) |
| Jun 2017 | - | -$4.55 M(-27.6%) | -$13.44 M(+51.2%) |
| Mar 2017 | - | -$6.28 M(+141.4%) | -$8.89 M(+241.4%) |
| Dec 2016 | -$26.11 M(-30.3%) | -$2.60 M | -$2.60 M |
| Dec 2015 | -$37.45 M | - | - |
FAQ
- What is Cardlytics annual EBITDA?
- What is the all time high annual EBITDA for Cardlytics?
- What is Cardlytics annual EBITDA year-on-year change?
- What is Cardlytics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cardlytics?
- What is Cardlytics quarterly EBITDA year-on-year change?
- What is Cardlytics TTM EBITDA?
- What is the all time high TTM EBITDA for Cardlytics?
- What is Cardlytics TTM EBITDA year-on-year change?
What is Cardlytics annual EBITDA?
The current annual EBITDA of CDLX is -$99.00 M
What is the all time high annual EBITDA for Cardlytics?
Cardlytics all-time high annual EBITDA is -$8.28 M
What is Cardlytics annual EBITDA year-on-year change?
Over the past year, CDLX annual EBITDA has changed by +$319.97 M (+76.37%)
What is Cardlytics quarterly EBITDA?
The current quarterly EBITDA of CDLX is -$135.30 M
What is the all time high quarterly EBITDA for Cardlytics?
Cardlytics all-time high quarterly EBITDA is $26.12 M
What is Cardlytics quarterly EBITDA year-on-year change?
Over the past year, CDLX quarterly EBITDA has changed by -$140.53 M (-2688.01%)
What is Cardlytics TTM EBITDA?
The current TTM EBITDA of CDLX is -$238.00 M
What is the all time high TTM EBITDA for Cardlytics?
Cardlytics all-time high TTM EBITDA is -$2.60 M
What is Cardlytics TTM EBITDA year-on-year change?
Over the past year, CDLX TTM EBITDA has changed by -$119.66 M (-101.11%)